BrainStorm Cell Therapeutics
BCLI
#10374
Rank
C$9.13 M
Marketcap
C$0.83
Share price
2.54%
Change (1 day)
-75.75%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : C$12.41 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total liabilities are C$12.41 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BrainStorm Cell Therapeutics - Total liabilities on balance sheet (from 2002 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$13.77 M14.51%
2023-12-31C$12.02 M-22.71%
2022-12-31C$15.55 M22.88%
2021-12-31C$12.66 M-37.13%
2020-12-31C$20.13 M-17.79%
2019-12-31C$24.49 M189.5%
2018-12-31C$8.46 M21.42%
2017-12-31C$6.96 M500.21%
2016-12-31C$1.16 M-71.65%
2015-12-31C$4.09 M9.05%
2014-12-31C$3.75 M77.54%
2013-12-31C$2.11 M84%
2012-12-31C$1.14 M-10.02%
2011-12-31C$1.27 M-17.43%
2010-12-31C$1.54 M-41.18%
2009-12-31C$2.63 M-26.69%
2008-12-31C$3.58 M2.44%
2007-12-31C$3.5 M18.48%
2006-12-31C$2.95 M
2006-03-31C$10.31 M4760.76%
2005-03-31C$0.21 M240.67%
2004-03-31C$0.06 M68.84%
2003-03-31C$0.03 M101.35%
2002-03-31C$0.01 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
C$50.72 B 408,552.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
C$2.67 B 21,476.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
C$1.48 B 11,845.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$15.04 B 121,138.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$0.70 B 5,573.53%๐Ÿ‡บ๐Ÿ‡ธ USA